{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T16:29:28Z","timestamp":1787416168044,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12127-9","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:52:40Z","timestamp":1781081560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Peripheral blood mRNA expression of IL37, IL1F10, and C17orf99 genes is altered in patients with B-acute lymphoblastic leukemia: a case-control study"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4167-4645","authenticated-orcid":false,"given":"Noor T.","family":"Kadhim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reema M.","family":"Abed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"12127_CR1","doi-asserted-by":"publisher","first-page":"e577","DOI":"10.1038\/BCJ.2017.53","volume":"7","author":"T Terwilliger","year":"2017","unstructured":"Terwilliger T, Abdul-Hay M (2017) Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J 7:e577. https:\/\/doi.org\/10.1038\/BCJ.2017.53","journal-title":"Blood Cancer J"},{"key":"12127_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ebiom.2016.04.038","volume":"8","author":"YF Liu","year":"2016","unstructured":"Liu YF, Wang BY, Zhang WN et al (2016) Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia. EBioMedicine 8:173\u2013183. https:\/\/doi.org\/10.1016\/j.ebiom.2016.04.038","journal-title":"EBioMedicine"},{"key":"12127_CR3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/cancers14020382","volume":"14","author":"FM Onyije","year":"2022","unstructured":"Onyije FM, Olsson A, Baaken D et al (2022) Environmental risk factors for childhood acute lymphoblastic leukemia: an umbrella review. Cancers (Basel) 14:382","journal-title":"Cancers (Basel)"},{"key":"12127_CR4","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/ajh.27708","volume":"100","author":"H Kantarjian","year":"2025","unstructured":"Kantarjian H, Jabbour E (2025) Adult acute lymphoblastic leukemia: 2025 update on diagnosis, therapy and monitoring. Am J Hematol 100:1205\u20131231. https:\/\/doi.org\/10.1002\/ajh.27708","journal-title":"Am J Hematol"},{"key":"12127_CR5","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.3390\/cancers14071805","volume":"14","author":"K Saleh","year":"2022","unstructured":"Saleh K, Fernandez A, Pasquier F (2022) Treatment of philadelphia chromosome-positive acute lymphoblastic leukemia in adults. Cancers (Basel) 14:1805. https:\/\/doi.org\/10.3390\/cancers14071805","journal-title":"Cancers (Basel)"},{"issue":"22","key":"12127_CR6","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3390\/cells13221906","volume":"13","author":"VP Chavda","year":"2024","unstructured":"Chavda VP, Feehan J, Apostolopoulos V (2024) Inflammation: the cause of all diseases. Cells 13(22):1906. https:\/\/doi.org\/10.3390\/cells13221906","journal-title":"Cells"},{"key":"12127_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/cells15050467","volume":"15","author":"C Simioni","year":"2026","unstructured":"Simioni C, Neri LM (2026) Cytokines, signaling and epigenetic mechanisms: shaping the acute lymphoblastic leukemia microenvironment. Cells 15:467. https:\/\/doi.org\/10.3390\/cells15050467","journal-title":"Cells"},{"issue":"1","key":"12127_CR8","doi-asserted-by":"publisher","first-page":"5530650","DOI":"10.1155\/2021\/5530650","volume":"2021","author":"F De Magalh\u00e3es-Gama","year":"2021","unstructured":"Magalh\u00e3es-Gama F, Kerr MWA, De Ara\u00fajo ND et al (2021) Imbalance of Chemokines and Cytokines in the Bone Marrow Microenvironment of Children with B\u2010Cell Acute Lymphoblastic Leukemia. J Oncol 2021(1):5530650. https:\/\/doi.org\/10.1155\/2021\/5530650","journal-title":"J Oncol"},{"key":"12127_CR9","doi-asserted-by":"publisher","first-page":"156267","DOI":"10.1016\/j.cyto.2023.156267","volume":"169","author":"Q Dai","year":"2023","unstructured":"Dai Q, Zhang G, Wang Y et al (2023) Cytokine network imbalance in children with B-cell acute lymphoblastic leukemia at diagnosis. Cytokine 169:156267. https:\/\/doi.org\/10.1016\/j.cyto.2023.156267","journal-title":"Cytokine"},{"key":"12127_CR10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41388-025-03293-4","volume":"44","author":"M Finucane","year":"2025","unstructured":"Finucane M, Brint E, Houston A (2025) The complex roles of IL-36 and IL-38 in cancer: friends or foes? Oncogene 44:851\u2013861. https:\/\/doi.org\/10.1038\/s41388-025-03293-4","journal-title":"Oncogene"},{"key":"12127_CR11","doi-asserted-by":"publisher","first-page":"1278521","DOI":"10.3389\/fimmu.2023.1278521","volume":"14","author":"M Gu","year":"2023","unstructured":"Gu M, Jin Y, Gao X et al (2023) Novel insights into IL-37: an anti-inflammatory cytokine with emerging roles in anti-cancer process. Front Immunol 14:1278521. https:\/\/doi.org\/10.3389\/fimmu.2023.1278521","journal-title":"Front Immunol"},{"key":"12127_CR12","doi-asserted-by":"publisher","first-page":"12552","DOI":"10.3390\/ijms222212552","volume":"22","author":"A Esmaeilzadeh","year":"2021","unstructured":"Esmaeilzadeh A, Bahmaie N, Nouri E et al (2021) Immunobiological properties and clinical applications of interleukin-38 for immune-mediated disorders: A systematic review study. Int J Mol Sci 22:12552. https:\/\/doi.org\/10.3390\/ijms222212552","journal-title":"Int J Mol Sci"},{"key":"12127_CR13","doi-asserted-by":"publisher","first-page":"3968767","DOI":"10.1155\/2024\/3968767","volume":"2024","author":"F Dabbagh-Gorjani","year":"2024","unstructured":"Dabbagh-Gorjani F (2024) A Comprehensive Review on the Role of Interleukin-40 as a Biomarker for Diagnosing Inflammatory Diseases. Autoimmune Dis 2024:3968767. https:\/\/doi.org\/10.1155\/2024\/3968767","journal-title":"Autoimmune Dis"},{"key":"12127_CR14","doi-asserted-by":"publisher","first-page":"156368","DOI":"10.1016\/j.cyto.2023.156368","volume":"171","author":"MA Bashi","year":"2023","unstructured":"Bashi MA, Ad\u2019hiah AH (2023) Interleukin-37 gene expression is down-regulated in patients with acute myeloid leukemia and shown to be affected by CD14 and HLA-DR immunophenotypes. Cytokine 171:156368. https:\/\/doi.org\/10.1016\/j.cyto.2023.156368","journal-title":"Cytokine"},{"key":"12127_CR15","doi-asserted-by":"publisher","first-page":"101612","DOI":"10.1016\/j.nexres.2026.101612","volume":"8","author":"MA Bashi","year":"2026","unstructured":"Bashi MA, Al-Qayyim MK, Ad\u2019hiah AH (2026) The gene encoding interleukin-38, IL1F10, showed down-regulated expression in acute myeloid leukemia particularly in CD34-positive newly diagnosed patients. Next Res 8:101612. https:\/\/doi.org\/10.1016\/j.nexres.2026.101612","journal-title":"Next Res"},{"key":"12127_CR16","doi-asserted-by":"publisher","first-page":"148214","DOI":"10.1016\/j.gene.2024.148214","volume":"904","author":"MA Bashi","year":"2024","unstructured":"Bashi MA, Ad\u2019hiah AH (2024) Molecular landscape of the interleukin-40 encoding gene, C17orf99, in patients with acute myeloid leukemia. Gene 904:148214. https:\/\/doi.org\/10.1016\/j.gene.2024.148214","journal-title":"Gene"},{"key":"12127_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3892\/etm.2022.11422","volume":"24","author":"H Zeng","year":"2022","unstructured":"Zeng H, Zhou K, Ye Z (2022) Biology of interleukin\u201337 and its role in autoimmune diseases (Review). Exp Ther Med 24:495. https:\/\/doi.org\/10.3892\/etm.2022.11422","journal-title":"Exp Ther Med"},{"key":"12127_CR18","doi-asserted-by":"publisher","first-page":"e991","DOI":"10.1002\/iid3.991","volume":"11","author":"W Chen","year":"2023","unstructured":"Chen W, Xi S, Ke Y, Lei Y (2023) The emerging role of IL-38 in diseases: A comprehensive review. Immun Inflamm Dis 11:e991. https:\/\/doi.org\/10.1002\/iid3.991","journal-title":"Immun Inflamm Dis"},{"key":"12127_CR19","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.4049\/jimmunol.1700534","volume":"199","author":"J Catalan-Dibene","year":"2017","unstructured":"Catalan-Dibene J, Vazquez MI, Luu VP et al (2017) Identification of IL-40, a Novel B Cell\u2013Associated Cytokine. J Immunol 199:3326\u20133335. https:\/\/doi.org\/10.4049\/jimmunol.1700534","journal-title":"J Immunol"},{"key":"12127_CR20","doi-asserted-by":"publisher","first-page":"156117","DOI":"10.1016\/j.cyto.2022.156117","volume":"162","author":"AS Jaber","year":"2023","unstructured":"Jaber AS, Ad\u2019hiah AH (2023) A novel signature of interleukins 36\u03b1, 37, 38, 39 and 40 in ankylosing spondylitis. Cytokine 162:156117. https:\/\/doi.org\/10.1016\/j.cyto.2022.156117","journal-title":"Cytokine"},{"key":"12127_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.molimm.2023.11.002","volume":"164","author":"DFN Bani-Wais","year":"2023","unstructured":"Bani-Wais DFN, Ad\u2019hiah AH (2023) A novel intergenic variant, rs2004339 A\/G, of the gene encoding interleukin-40, C17orf99, is associated with risk of rheumatoid arthritis in Iraqi women. Mol Immunol 164:39\u201346. https:\/\/doi.org\/10.1016\/j.molimm.2023.11.002","journal-title":"Mol Immunol"},{"key":"12127_CR22","doi-asserted-by":"publisher","first-page":"201555","DOI":"10.1016\/j.humgen.2026.201555","volume":"48","author":"RA Nijeeb","year":"2026","unstructured":"Nijeeb RA, Aljber AA, Ad\u2019hiah AH (2026) Serum IL-40 levels are elevated in women with systemic lupus erythematosus, and intergenic variants of encoding gene (C17orf99) are associated with disease susceptibility. Hum Gene 48:201555. https:\/\/doi.org\/10.1016\/j.humgen.2026.201555","journal-title":"Hum Gene"},{"key":"12127_CR23","doi-asserted-by":"publisher","first-page":"448","DOI":"10.32768\/abc.5801274963-802","volume":"12","author":"SA Hameed","year":"2025","unstructured":"Hameed SA, Abed RM (2025) Elevated serum interleukin-40 levels and gene expression as novel biomarkers in iraqi women with breast cancer. Arch Breast Cancer 12:448\u2013456. https:\/\/doi.org\/10.32768\/abc.5801274963-802","journal-title":"Arch Breast Cancer"},{"key":"12127_CR24","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP et al (2022) International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood 140:1200\u20131228. https:\/\/doi.org\/10.1182\/blood.2022015850","journal-title":"Blood"},{"key":"12127_CR25","first-page":"1","volume":"1","author":"G Koetsier","year":"2019","unstructured":"Koetsier G, Cantor E (2019) A practical guide to analyzing nucleic acid concentration and purity with microvolume spectrophotometers. New Engl Biolabs 1:1\u20138","journal-title":"New Engl Biolabs"},{"key":"12127_CR26","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA et al (2009) The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611\u2013622. https:\/\/doi.org\/10.1373\/clinchem.2008.112797","journal-title":"Clin Chem"},{"key":"12127_CR27","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3:1101\u20131108. https:\/\/doi.org\/10.1038\/nprot.2008.73","journal-title":"Nat Protoc"},{"key":"12127_CR28","doi-asserted-by":"publisher","first-page":"201516","DOI":"10.1016\/j.humgen.2025.201516","volume":"47","author":"TA Kadhim","year":"2026","unstructured":"Kadhim TA, Ghamyes RR, Azeez DA et al (2026) Low GOPC mRNA expression is a novel candidate associated with increased risk of acute myeloid leukemia. Hum Gene 47:201516. https:\/\/doi.org\/10.1016\/j.humgen.2025.201516","journal-title":"Hum Gene"},{"key":"12127_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.53941\/tai.2025.100005","volume":"1","author":"F Deng","year":"2025","unstructured":"Deng F, Feng CH, Gao N, Zhang L (2025) Normalization and selecting non-differentially expressed genes improve machine learning modelling of cross-platform transcriptomic data. Trans Artif Intell 1:5. https:\/\/doi.org\/10.53941\/tai.2025.100005","journal-title":"Trans Artif Intell"},{"key":"12127_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3352\/JEEHP.2021.18.17","volume":"18","author":"H Kang","year":"2021","unstructured":"Kang H (2021) Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof 18:17. https:\/\/doi.org\/10.3352\/JEEHP.2021.18.17","journal-title":"J Educ Eval Health Prof"},{"key":"12127_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/tjem.tjem_182_23","volume":"23","author":"\u015eK \u00c7orbac\u0131o\u011flu","year":"2023","unstructured":"\u00c7orbac\u0131o\u011flu \u015eK, Aksel G (2023) Receiver operating characteristic curve analysis in diagnostic accuracy studies: A guide to interpreting the area under the curve value. Turkish J Emerg Med 23:195\u2013198. https:\/\/doi.org\/10.4103\/tjem.tjem_182_23","journal-title":"Turkish J Emerg Med"},{"key":"12127_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","volume":"18","author":"H Akoglu","year":"2018","unstructured":"Akoglu H (2018) User\u2019s guide to correlation coefficients. Turkish J Emerg Med 18:91\u201393. https:\/\/doi.org\/10.1016\/j.tjem.2018.08.001","journal-title":"Turkish J Emerg Med"},{"key":"12127_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/cdd.2014.89","volume":"22","author":"C Riether","year":"2015","unstructured":"Riether C, Sch\u00fcrch CM, Ochsenbein AF (2015) Regulation of hematopoietic and leukemic stem cells by the immune system. Cell Death Differ 22:187\u2013198. https:\/\/doi.org\/10.1038\/cdd.2014.89","journal-title":"Cell Death Differ"},{"key":"12127_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.32725\/jab.2024.024","volume":"22","author":"M \u0160tajer","year":"2024","unstructured":"\u0160tajer M, Hor\u00e1\u010dek JM, Kupsa T, \u017d\u00e1k P (2024) The role of chemokines and interleukins in acute lymphoblastic leukemia: a systematic review. J Appl Biomed 22:165\u2013184. https:\/\/doi.org\/10.32725\/jab.2024.024","journal-title":"J Appl Biomed"},{"key":"12127_CR35","doi-asserted-by":"publisher","first-page":"2604877","DOI":"10.1080\/2162402X.2025.2604877","volume":"15","author":"N Landolina","year":"2026","unstructured":"Landolina N, Mariotti FR, Munari E et al (2026) IL-37\/IL-1R8 axis: a novel major mechanism of control at the interface between tumor and immune cells. Oncoimmunology 15:2604877. https:\/\/doi.org\/10.1080\/2162402X.2025.2604877","journal-title":"Oncoimmunology"},{"key":"12127_CR36","doi-asserted-by":"publisher","first-page":"2212673","DOI":"10.1080\/19420862.2023.2212673","volume":"15","author":"JP Dowling","year":"2023","unstructured":"Dowling JP, Nikitin PA, Shen F et al (2023) IL-38 blockade induces anti-tumor immunity by abrogating tumor-mediated suppression of early immune activation. MAbs 15:2212673. https:\/\/doi.org\/10.1080\/19420862.2023.2212673","journal-title":"MAbs"},{"key":"12127_CR37","doi-asserted-by":"publisher","first-page":"e008641","DOI":"10.1136\/jitc-2023-008641","volume":"12","author":"P Da Silva","year":"2024","unstructured":"Da Silva P, Mora J, You X et al (2024) Neutralizing IL-38 activates \u03b3\u03b4T cell-dependent antitumor immunity and sensitizes for chemotherapy. J Immunother Cancer 12:e008641. https:\/\/doi.org\/10.1136\/jitc-2023-008641","journal-title":"J Immunother Cancer"},{"key":"12127_CR38","doi-asserted-by":"publisher","first-page":"e53791","DOI":"10.15252\/embr.202153791","volume":"23","author":"H Zhou","year":"2022","unstructured":"Zhou H, Zhao Q, Yue C et al (2022) Interleukin-38 promotes skin tumorigenesis in an IL\u20101Rrp2\u2010dependent manner. EMBO Rep 23:e53791. https:\/\/doi.org\/10.15252\/embr.202153791","journal-title":"EMBO Rep"},{"key":"12127_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2023.01.006","volume":"254","author":"SW Nussrat","year":"2023","unstructured":"Nussrat SW, Ad\u2019hiah AH (2023) Interleukin-40 is a promising biomarker associated with type 2 diabetes mellitus risk. Immunol Lett 254:1\u20135. https:\/\/doi.org\/10.1016\/j.imlet.2023.01.006","journal-title":"Immunol Lett"},{"key":"12127_CR40","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.exger.2015.09.017","volume":"72","author":"Y Cruz-Almeida","year":"2015","unstructured":"Cruz-Almeida Y, Aguirre M, Sorenson HL et al (2015) Age differences in cytokine expression under conditions of health using experimental pain models. Exp Gerontol 72:150\u2013156. https:\/\/doi.org\/10.1016\/j.exger.2015.09.017","journal-title":"Exp Gerontol"},{"key":"12127_CR41","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.clml.2017.03.299","volume":"17","author":"CH Pui","year":"2017","unstructured":"Pui CH, Roberts KG, Yang JJ, Mullighan CG (2017) Philadelphia Chromosome\u2013like Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk 17:464\u2013470. https:\/\/doi.org\/10.1016\/j.clml.2017.03.299","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12127-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12127-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12127-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:52:41Z","timestamp":1781081561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12127-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12127"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12127-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"926"}}